Stock Scorecard
Stock Summary for Ekso Bionics Holdings Inc (EKSO) - $4.60 as of 12/3/2025 3:51:06 PM EST
Total Score
12 out of 30
Safety Score
19 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EKSO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EKSO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EKSO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EKSO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EKSO (19 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EKSO
Financial Details for EKSO
Company Overview |
|
|---|---|
| Ticker | EKSO |
| Company Name | Ekso Bionics Holdings Inc |
| Country | USA |
| Description | Ekso Bionics Holdings, Inc. is a pioneering leader in the design and development of advanced exoskeleton technology aimed at enhancing mobility and rehabilitation for individuals with physical impairments. Based in Richmond, California, Ekso Bionics offers a range of innovative exoskeleton products and rental options, serving a diverse clientele that includes healthcare providers and industrial sectors. The company’s focus on improving patient outcomes and maximizing human performance positions it favorably within the emerging wearable robotics market, representing a compelling investment opportunity for institutional investors seeking to capitalize on advancements in healthcare technology. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 4.60 |
| Price 4 Years Ago | 39.75 |
| Last Day Price Updated | 12/3/2025 3:51:06 PM EST |
| Last Day Volume | 76,313 |
| Average Daily Volume | 41,017 |
| 52-Week High | 14.97 |
| 52-Week Low | 2.73 |
| Last Price to 52 Week Low | 68.50% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 389.65 |
| Sector PE | 88.06 |
| 5-Year Average PE | -22.38 |
| Free Cash Flow Ratio | 4.42 |
| Industry Free Cash Flow Ratio | 42.91 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 1.66 |
| Total Cash Per Share | 1.04 |
| Book Value Per Share Most Recent Quarter | 3.69 |
| Price to Book Ratio | 1.25 |
| Industry Price to Book Ratio | 3.52 |
| Sector Price to Book Ratio | 33.12 |
| Price to Sales Ratio Twelve Trailing Months | 0.79 |
| Industry Price to Sales Ratio Twelve Trailing Months | 46.33 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.97 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 2,623,200 |
| Market Capitalization | 12,066,720 |
| Institutional Ownership | 7.73% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 25.45% |
| Reported EPS 12 Trailing Months | -5.17 |
| Reported EPS Past Year | -1.90 |
| Reported EPS Prior Year | -0.57 |
| Net Income Twelve Trailing Months | -10,434,000 |
| Net Income Past Year | -11,330,000 |
| Net Income Prior Year | -15,198,000 |
| Quarterly Revenue Growth YOY | 2.40% |
| 5-Year Revenue Growth | 5.19% |
| Operating Margin Twelve Trailing Months | -33.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,722,000 |
| Total Cash Past Year | 6,493,000 |
| Total Cash Prior Year | 8,638,000 |
| Net Cash Position Most Recent Quarter | 1,652,000 |
| Net Cash Position Past Year | 2,639,000 |
| Long Term Debt Past Year | 3,854,000 |
| Long Term Debt Prior Year | 4,832,000 |
| Total Debt Most Recent Quarter | 1,070,000 |
| Equity to Debt Ratio Past Year | 0.77 |
| Equity to Debt Ratio Most Recent Quarter | 0.90 |
| Total Stockholder Equity Past Year | 12,707,000 |
| Total Stockholder Equity Prior Year | 12,606,000 |
| Total Stockholder Equity Most Recent Quarter | 9,679,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -9,024,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -3.44 |
| Free Cash Flow Past Year | -9,883,000 |
| Free Cash Flow Prior Year | -12,211,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.15 |
| MACD Signal | -0.14 |
| 20-Day Bollinger Lower Band | 2.94 |
| 20-Day Bollinger Middle Band | 4.37 |
| 20-Day Bollinger Upper Band | 5.80 |
| Beta | 0.81 |
| RSI | 49.41 |
| 50-Day SMA | 5.84 |
| 150-Day SMA | 15.16 |
| 200-Day SMA | 18.71 |
System |
|
| Modified | 12/3/2025 10:27:26 PM EST |